Dash Technologies Inc

Real-world data clinical trials are not a workaround but are a design upgrade. The traditional controlled trial model: controlled populations, site-based enrollment, manual review, built clear evidence slowly and at high cost , from populations that represented a narrow slice of those who actually take the drug, and the FDA recognized that gap. Pharma organizations building evidence programs around RWD generate faster data, at lower cost, from populations that look like the real patient population. The ones still running site-only trials are paying for constraints they no longer have to accept.   The cost difference is not marginal. Site-based enrollment for a Phase III program runs on years of referral chains, travel requirements, and geographic exclusions that systematically underrepresent rural and minority populations. RWD cuts those constraints. The trial runs on patients who already exist in the health system data.   What Is Real-World Data in Healthcare?   Re...

  Innovation must meet trust, safety and regulation—especially in regulated industries such as healthcare, MedTech and aerospace. At Dash Technologies, our QA & Regulatory Compliance service brings decades of experience in building quality systems, conducting validation, managing audits and delivering market-ready products.    Whether you’re developing software as a medical device (SaMD), connected hardware, or enterprise platforms with strict compliance demands, we provide robust QA engineering, documentation, risk management and lifecycle support. With Dash, your solutions aren’t just technically excellent— they’re certified, trusted and ready for global markets.   Our Quality Assurance & Regulatory Compliance Spectrum   Our QA & Regulatory Compliance Services includes:   Quality Management Systems (QMS) Design & Implementation – ISO 13485, ISO 14971, FDA 21 CFR Part 11 compliant frameworks.   Verification & Validation En...